Page last updated: 2024-12-05

3-tolylcarbamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

3-tolylcarbamide: derivative of anticonvulsant phenylcarbamide; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6142
SCHEMBL ID166848
MeSH IDM0044653

Synonyms (50)

Synonym
HMS1775L15
urea, m-tolyl-
urea, (3-methylphenyl)-
m-tolylurea
3-methylphenylurea
nsc2177
wln: zvmr c1
63-99-0
m-tolylcarbamide
nsc-2177
MTK ,
brn 2639488
nsc 2177
(3-methylphenyl)urea
3-tolylcarbamide
einecs 200-571-8
ai3-61313
metatolylcarbamide
3-tolylurea
inchi=1/c8h10n2o/c1-6-3-2-4-7(5-6)10-8(9)11/h2-5h,1h3,(h3,9,10,11)
uvqvmniyfxzxci-uhfffaoysa-
AKOS000150951
A834605
1-(m-tolyl)urea
STL124184
1-(3-methylphenyl)urea
4-12-00-01828 (beilstein handbook reference)
uv03u47557 ,
unii-uv03u47557
FT-0629024
FS-1554
n-(3-methylphenyl)urea
SCHEMBL166848
n'-(3-methylphenyl)urea
n-(m-tolyl) urea
m-tolyl urea
n-[3-methylphenyl]urea
meta-tolylurea
n-(3-methylphenyl)urea #
urea, n-(3-methylphenyl)-
DTXSID1075351
n-m-tolylurea
m-methylphenylurea
mfcd00025425
Z56754678
(2s,3s)-3-amino-2-hydroxy-5-methyl-hexanoicacid
1-m-tolylurea
Q27291286
SB76719
CS-0326794
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (50.00)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]